These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1635498)

  • 1. Immunosuppression in transplantation.
    Russ GR
    Med J Aust; 1992 Aug; 157(3):198-203. PubMed ID: 1635498
    [No Abstract]   [Full Text] [Related]  

  • 2. Nursing implications of immunosuppression in transplantation.
    Shaefer M; Williams L
    Nurs Clin North Am; 1991 Jun; 26(2):291-314. PubMed ID: 1904575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of antilymphocyte induction therapy in liver transplantation: A European perspective.
    Langrehr JM; Neuhaus PJ
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S71-84. PubMed ID: 10431020
    [No Abstract]   [Full Text] [Related]  

  • 4. Pancreas transplantation with ATG vs OKT3.
    Rosenberg L
    Transplant Proc; 1997 Nov; 29(7A):35S-36S. PubMed ID: 9366927
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of immunosuppressive drugs in transplantation.
    Triemer H
    J Med Assoc Ga; 1998 Apr; 87(2):93-6. PubMed ID: 16259250
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody induction therapy in pancreas transplantation.
    Gruessner RW
    Transplant Proc; 1998 Jun; 30(4):1556-9. PubMed ID: 9636632
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody therapy in steroid-resistant rejection.
    Waiser J; Budde K; Schreiber M; Böhler T; Löbermann LA; Neumayer HH
    Transplant Proc; 1998 Aug; 30(5):1778-9. PubMed ID: 9723279
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppression is not related to the response to steroids in acute liver rejection.
    Bercedo J; Jiménez C; Moreno E; García MA; Palomo JC; Loinaz C; Marcello M; Moreno C; Chamorro A; Manzanera M
    Transplant Proc; 1995 Aug; 27(4):2328-9. PubMed ID: 7652830
    [No Abstract]   [Full Text] [Related]  

  • 9. Antilymphocyte-antibody prophylaxis: review of the adult experience in heart transplantation.
    Taylor DO; Kfoury AG; Pisani B; Hammond EH; Renlund DG
    Transplant Proc; 1997 Dec; 29(8A):13S-15S. PubMed ID: 9414668
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantation.
    Klupp J; Bechstein WO; Pratschke J; Tullius SG; Gebhard A; Lobeck H; Langrehr JM; Neuhaus R; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1443-4. PubMed ID: 9636585
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful therapy of chronic renal allograft failure by enhanced immunosuppression.
    Kliem V; Tiroke T; Ehlerding G; Eberhard O; Behrend M; Frei U; Koch KM; Pichlmayr R; Brunkhorst R
    Transplant Proc; 1998 Jun; 30(4):1207-9. PubMed ID: 9636490
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of various immunosuppressive regimes in second renal transplants.
    Toronyi E; Remport A; Járay J; Máthé Z; Borka P; Perner F
    Transplant Proc; 2001 May; 33(3):2315-6. PubMed ID: 11377543
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation.
    Lange D; Bechstein WO; Blumhardt G; Lemmens P; Schattenfroh N; Neuhaus P
    Transplant Proc; 1993 Apr; 25(2):1870-1. PubMed ID: 8470207
    [No Abstract]   [Full Text] [Related]  

  • 14. Graft outcome in patients with biopsy-proven chronic renal allograft rejection.
    Peddi VR; Schroeder TJ; Weiskittel P; First MR
    Transplant Proc; 1999; 31(1-2):1308-9. PubMed ID: 10083584
    [No Abstract]   [Full Text] [Related]  

  • 15. Importance of degree of eosinophilia in inflammatory infiltrates within renal allografts in the response to immunosuppressive treatment.
    Papadimitriou JC; Nogueira J; Fink JC; Klassen DK; Bartlett ST; Weir MR; Drachenberg CB
    Transplant Proc; 1998 Jun; 30(4):1181. PubMed ID: 9636477
    [No Abstract]   [Full Text] [Related]  

  • 16. Strategies of immunosuppression in cardiac transplantation.
    Renlund DG; O'Connell JB; Bristow MR
    Semin Thorac Cardiovasc Surg; 1990 Apr; 2(2):181-8. PubMed ID: 2127901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients.
    Mariat C; Alamartine E; Diab N; de Filippis JP; Laurent B; Berthoux F
    Transpl Int; 1998; 11(3):231-6. PubMed ID: 9638854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation.
    Bruce DS; Newell KA; Woodle ES; Millis JM; Piper JB; Huss E; Thistlethwaite JR
    Transplant Proc; 1996 Aug; 28(4):2136-7. PubMed ID: 8769180
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of steroid resistant acute rejection after renal transplantation.
    Oh CK; Kim YS; Kim MS; Kim SI; Park K
    Transplant Proc; 1996 Jun; 28(3):1453-4. PubMed ID: 8658737
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunosuppressive therapy].
    Nakamura H
    Rinsho Byori; 1991 Jul; Suppl 90():102-14. PubMed ID: 1920848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.